A Point Biopharma Global cancer therapy key to a $1.4 billion Eli Lilly M&A deal has met the main goal of its pivotal clinical trial in prostate cancer. But the results raise questions about how well ...
Prostate-specific antigen (PSA) is a uniquely valid tumor marker for prostate cancer screening and early detection. 1 The widespread use of serum PSA testing for early prostate cancer detection has ...
The Hearty Soul on MSN
What are the symptoms of prostate cancer and what should you check for?
Know the 8 prostate cancer symptoms to watch for, from urinary changes to bone pain, plus who is most at risk and when to get ...
NORTH BILLERICA, Mass.--(BUSINESS WIRE)-- Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., a global leader ...
Why would any healthy person, newly diagnosed with cancer, elect not to undergo curative treatment? Newly diagnosed prostate cancer patients presented with the option of active surveillance often ask ...
Prostate cancer is absurdly common, but many men are mum about it. Joe Biden’s diagnosis has focused public attention on it. Good morning. I’m Mark Shanahan, guest-writing Starting Point to tell you ...
J Natl Compr Canc Netw. 2007;5(7):693-698. The primary concern with using PSADT as a trigger for curative intervention is that it may act as a marker of aggressive disease that has already progressed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results